CXCL9 and Miyoshi myopathy: High serum levels of CXCL9 and CXCL10, closely related inflammatory cytokines interacting with chemokine receptor CXCR3, have been proposed as potential biomarkers of MM progression associated with poor overall survival (83, 84).